Search
Apimeds Pharmaceuticals US Inc
APUSAdd to Watchlist
0.900USD
+0.005+0.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
11.32MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+0.58%
5 Days
0.00%
1 Month
-36.17%
6 Months
-45.95%
Year to Date
-45.12%
1 Year
-49.44%
Key Figures
0.932Open
0.950High
188.93KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
1.50%Turnover Ratio
0.885Prev. Close
0.861Low
127.94KTurnover
LossP/E Static
0.09P/B
0.00%Div Yield TTM
-7.31%ROA
4.03152wk High
1.13Volume Ratio
-1.39MNet Profit
12.58MShares
-0.5515EPS TTM
--Beta
-7.90%ROE
0.95152wk Low
10.07%Amplitude
--Gross Margin
11.32MMarket Cap
-3.98Reward/Risk
9.34%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Apimeds Pharmaceuticals US Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Apimeds Pharmaceuticals US Inc Info
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Ticker SymbolAPUS
CompanyApimeds Pharmaceuticals US Inc
CEOMenon (Vin)
Websitehttps://www.apimedsus.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Apimeds Pharmaceuticals US Inc (APUS)?
The current price of Apimeds Pharmaceuticals US Inc (APUS) is 0.90.
What is the symbol of Apimeds Pharmaceuticals US Inc?
The ticker symbol of Apimeds Pharmaceuticals US Inc is APUS.
What is the 52-week high of Apimeds Pharmaceuticals US Inc?
The 52-week high of Apimeds Pharmaceuticals US Inc is 4.03.
What is the 52-week low of Apimeds Pharmaceuticals US Inc?
The 52-week low of Apimeds Pharmaceuticals US Inc is 0.95.
What is the market capitalization of Apimeds Pharmaceuticals US Inc?
The market capitalization of Apimeds Pharmaceuticals US Inc is 11.32M.
What is the Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS)?
The Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS) is -0.55.